Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and potential efficacy of ANT-301 in knee osteoarthritis is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• ANT-301

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Osteoarthritis, Knee | Phase 1 | Status: ACTIVE_NOT_RECRUITING